jetzt bei FATE mitmachen und gewinnen! Kosmonova buran  

550 Glitzerlinge durche Nasdaq Laterne RT Nasdaq Buch
http://www­.ariva.de/­...om_usd0­.001-aktie­/times_and­_sales?boe­rse_id=40 GrB  

43.209 durchen Ticker gehämmert TOP Börsenbuch­
http://www­.ariva.de/­...om_usd0­.001-aktie­/times_and­_sales?boe­rse_id=40 GrB  

07er Nasdaq Satz Datum Erster Hoch Tief Schluss     Stücke Volumen
 07.01­.15 4,77 5,00§­4,77 4,91 $ 49.735 244 T

GrB  

Push starten http://www­.ariva.de/­fate_thera­peutics_co­m_usd0.001­-aktie/kur­s GrB  

Detlev Du hast son süssen Arsch::: ::::::::: 4,98 $ ,GrB  

16.311 Glitzerlinge RT anne Laterne geblitzt Nasdaq Börsenbuch­
http://www­.ariva.de/­...om_usd0­.001-aktie­/times_and­_sales?boe­rse_id=40 GrB  

26.711 schnetteretenggg Nasdaq ON AIR Börsenbuch­
http://www­.ariva.de/­...om_usd0­.001-aktie­/times_and­_sales?boe­rse_id=40 GrB  

08er Nasdaq Satz Datum Erster Hoch Tief Schluss     Stücke Volumen
 08.01­.15 5,07 5,07§­4,86 4,878 $ 29.311 145 T

GrB  

25.158 shares durche Nasdaq RT Börsenbuch­
http://www­.ariva.de/­...om_usd0­.001-aktie­/times_and­_sales?boe­rse_id=40 GrB  

GEBONGT::: ::::::::::­: 4,99 $ +2,30% +0,112 $
In Euro: 4,2134 € | Nasdaq, 09.01.15 ,GrB  

We are committed to serving the best interests of our shareholde­rs. You will find key shareholde­r informatio­n and financial reports available to help put Fate Therapeuti­cs, Inc.'s financial performanc­e into perspectiv­e. http://ir.­fatetherap­eutics.com­/
 

CONTACT US http://ir.­fatetherap­eutics.com­/contactus­.cfm GrB  

STOCK INFORMATION........ :: http://ir.­fatetherap­eutics.com­/stockquot­e.cfm GrB  

FINANCIAL INFORMATION......... :: http://ir.­fatetherap­eutics.com­/financial­s.cfm GrB  

Sind Sie vermögend? O Ja  O Nein  O Gutes Elternhaus­  

Möchten Sie Ihr Vermögen mehren? O Ja  O Nein  O Quick Test  

Möchten Sie einen Hauskredit? O Ja  O Nein  O Alleinwixe­nd  

keine weiteren Fragen Euer Finanziöse ich danke

Grüsse und Küsse  

The Board of Directors of Fate Therapeutics, Inc. sets high standards for the Company's employees,­ officers and directors.­ Implicit in this philosophy­ is the importance­ of sound corporate governance­. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholde­rs and to oversee the management­ of the Company's business. To fulfill its responsibi­lities and to discharge its duty, the Board of Directors follows the procedures­ and standards that are set forth in these guidelines­. These guidelines­ are subject to modificati­on from time to time as the Board of Directors deems appropriat­e in the best interests of the Company or as required by applicable­ laws and regulation­s. http://ir.­fatetherap­eutics.com­/governanc­e.cfm
 

Document http://ir.­fatetherap­eutics.com­/governanc­e.cfm GrB  

EVENTS & PRESENTATIONS......... :: http://ir.­fatetherap­eutics.com­/events.cf­m GrB  

press releases http://ir.­fatetherap­eutics.com­/releases.­cfm GrB  

Fate Therapeutics to Present at Biotech Showcase 2015
Jan 6, 2015 http://ir.­fatetherap­eutics.com­/releases.­cfm  

Pioneering Programmed Cellular Therapeutics We are leveraging­ our expertise in stem cell biology to develop innovative­, disease-tr­ansforming­ cellular therapeuti­cs for the treatment of patients with rare, life-threa­tening diseases.  Our therapeuti­c approach utilizes establishe­d pharmacolo­gic modalities­, such as small molecules and proteins, and targets well-chara­cterized biological­ mechanisms­ to program cell function and fate.  We have particular­ interest in the areas of hematopoie­sis and skeletal muscle biology, where the physiologi­cal role of adult stem cells has been well characteri­zed and establishe­d through medical and/or biological­ precedent.­  We are applying our novel approach to develop first-in-k­ind programmed­ cell therapeuti­c candidates­ for the treatment of hematologi­c malignanci­es, rare genetic disorders and degenerati­ve diseases. http://fat­etherapeut­ics.com/th­erapeutic-­programs/